BOM:500259 (India)
Â
Shs Dematerialised
₹
157.50
(+0.77%)
Nov 29
Business Description
Lyka Labs Ltd
ISIN : INE933A01014
Share Class Description:
BOM:500259: Shs DematerialisedCompare
Compare
Traded in other countries / regions
500259.India IPO Date
1992-03-02Description
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 1.87 | |||||
| Interest Coverage | 2.37 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.57 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.9 | |||||
| 3-Year EBITDA Growth Rate | -10.5 | |||||
| 3-Year EPS without NRI Growth Rate | 40.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.33 | |||||
| 9-Day RSI | 69.17 | |||||
| 14-Day RSI | 62.64 | |||||
| 6-1 Month Momentum % | 31.91 | |||||
| 12-1 Month Momentum % | 4.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.48 | |||||
| Quick Ratio | 1.23 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 62.04 | |||||
| Days Sales Outstanding | 91.25 | |||||
| Days Payable | 91.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 | |||||
| Shareholder Yield % | 3.34 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.43 | |||||
| Operating Margin % | 6.32 | |||||
| Net Margin % | 2.69 | |||||
| FCF Margin % | -5.94 | |||||
| ROE % | 4.31 | |||||
| ROA % | 2.13 | |||||
| ROIC % | 2.92 | |||||
| ROC (Joel Greenblatt) % | 10.51 | |||||
| ROCE % | 7.74 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 171.75 | |||||
| PE Ratio without NRI | 185.62 | |||||
| PS Ratio | 4.55 | |||||
| PB Ratio | 5.63 | |||||
| Price-to-Tangible-Book | 6.37 | |||||
| Price-to-Operating-Cash-Flow | 290.52 | |||||
| EV-to-EBIT | 61.96 | |||||
| EV-to-EBITDA | 31.42 | |||||
| EV-to-Revenue | 4.69 | |||||
| EV-to-FCF | -73.76 | |||||
| Price-to-Projected-FCF | 2.24 | |||||
| Price-to-Median-PS-Value | 2.65 | |||||
| Price-to-Graham-Number | 7.27 | |||||
| Earnings Yield (Greenblatt) % | 1.61 | |||||
| FCF Yield % | -1.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lyka Labs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,255.379 | ||
| EPS (TTM) (₹) | 0.91 | ||
| Beta | 0.62 | ||
| Volatility % | 39.7 | ||
| 14-Day RSI | 62.64 | ||
| 14-Day ATR (₹) | 7.922304 | ||
| 20-Day SMA (₹) | 147.435 | ||
| 12-1 Month Momentum % | 4.9 | ||
| 52-Week Range (₹) | 99.95 - 172.65 | ||
| Shares Outstanding (Mil) | 35.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lyka Labs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lyka Labs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lyka Labs Ltd Frequently Asked Questions
What is Lyka Labs Ltd(BOM:500259)'s stock price today?
The current price of BOM:500259 is ₹157.50. The 52 week high of BOM:500259 is ₹172.65 and 52 week low is ₹99.95.
When is next earnings date of Lyka Labs Ltd(BOM:500259)?
The next earnings date of Lyka Labs Ltd(BOM:500259) is .
Does Lyka Labs Ltd(BOM:500259) pay dividends? If so, how much?
Lyka Labs Ltd(BOM:500259) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers